Based on these data, we speculated that the mechanism of YAP1 promotion of ESCC development may be related to Ezrin, which has a regulatory effect on the YAP1/CTGF signaling pathway. The gene discussed is CCN2; the disease is esophageal squamous cell carcinoma.